Christopher Frederick Webber

Title: Christopher Frederick Webber: Innovator in Immunogenic Compositions

Introduction

Christopher Frederick Webber is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of immunology, particularly through his innovative patent related to immunogenic compositions. His work aims to enhance immune responses against specific infections, showcasing his dedication to advancing medical science.

Latest Patents

Webber holds a patent for "Immunogenic compositions against and methods thereof." This invention involves an immunogenic composition that includes atoxoid A and/or atoxoid B. The patent outlines methods for eliciting an immune response in humans against infections. The method includes administering an effective dose of the composition at least two times, ensuring a sustained immune response against toxin A and/or toxin B. This patent highlights his innovative approach to immunology and its potential impact on public health.

Career Highlights

Christopher Webber is associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on groundbreaking research and development projects that aim to improve health outcomes. His expertise in immunogenic compositions positions him as a valuable asset in the field of vaccine development and infectious disease management.

Collaborations

Webber collaborates with esteemed colleagues, including Annaliesa Sybil Anderson and Alexey Vyacheslavovitch Gribenko. These partnerships enhance the research and development efforts at Pfizer, fostering an environment of innovation and scientific discovery.

Conclusion

Christopher Frederick Webber's contributions to immunology through his patent and work at Pfizer Corporation exemplify his commitment to advancing medical science. His innovative approaches have the potential to significantly impact public health and improve immune responses against infections.